'It is an exciting and busy time for us'
Sam Lynch has BioMimetic on a steady growth path. Next up: Two important product launches.
Dr. Samuel Lynch is president and CEO of BioMimetic Therapeutics Inc. The Franklin-based company develops drugs for the repair of orthopedic injuries to bone, cartilage, ligaments and tendons. BioMimetic late last year won an important patent for its regenerative tissues and recently wrapped up a stock offering. Lynch sat down to discuss his company’s growth with Post news correspondent William Williams.
Read Entire Article.
